Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression

Abstract

The potential tumor suppressor protein prohibitin can prevent cell proliferation and this required its binding to the Rb protein. Prohibitin could repress the transcriptional activity of E2F family members and this required a part of the marked box region of E2F. The sub-cellular localization of prohibitin has been variously attributed to the mitochondria as well as the inner cell membrane. Here we show that a subset of prohibitin molecules are present in the nucleus where it co-localizes with the Rb protein. Deletion of a putative amino-terminal membrane-docking domain of prohibitin had no effect on its ability to suppress cell proliferation or inhibit E2F activity. Our experiments show that a 53 amino-acid stretch of E2F1 is sufficient for being targeted by prohibitin; fusion of this region to GAL4–VP16 construct could make it susceptible to prohibitin-mediated, but not Rb-mediated repression. Prohibitin, like Rb, could repress transcription from SV40 and major late promoters when recruited directly to DNA. Prohibitin mediated transcriptional repression required histone-deacetylase activity, but unlike Rb, additional co-repressors like N-CoR are also involved. Repression by prohibitin correlates with histone deacetylation on promoters and this was reversed by IgM stimulation of cells; IgM did not affect Rb-mediated repression or deacetylation of the promoters. Prohibitin thus appears to repress E2F-mediated transcription utilizing different molecular mediators and facilitate channeling of specific signaling pathways to the cell cycle machinery.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Adams PD, Kaelin WJ . 1995 Semin. Cancer Biol. 6: 99–108

  • Adams PD, Kaelin WJ . 1996 Curr. Top. Microbiol. Immunol. 208: 79–93

  • Adnane J, Shao Z, Robbins PD . 1995 J. Biol. Chem. 270: 8837–8843

  • Alberts AS, Geneste O, Triesman R . 1998 Cell 92: 475–487

  • Amann JM, Nip J, Strom D, Lutterbach B, Harada H, Lenny N, Downing JR, Meyers S, Hiebert SW . 2001 Mol. Cell. Biol. 21: 6470–6483

  • Brehm A, Kouzarides T . 1999 Trends Biochem. Sci. 24: 142–145

  • Brehm A, Miska EA, McCance D, Reid JL, Bannister AJ, Kouzarides T . 1998 Nature 391: 597–601

  • Coates PJ, Nenutil R, McGregor A, Picksley SM, Crouch D, Hall PA, Wright EG . 2001 Exp. Cell Res. 265: 262–273

  • Collingwood TM, Urnov FD, Wolffe AP . 1999 J. Mol. Endocrinol. 23: 255–275

  • Dahiya A, Wong S, Gonzalo S, Gavin M, Dean DC . 2001 Mol. Cell 8: 557–569

  • Dedon PC, Soults JA, Allis CC, Gorovsky MA . 1991 Analytical. Biochem. 197: 83–90

  • Delage-Mourroux R, Martini PG, Choi I, Kraichely DM, Hoeksema J, Katzenellenbogen BS . 2000 J. Biol. Chem. 275: 35848–35856

  • Dyson N . 1998 Genes Dev. 12: 2245–2262

  • Fusaro G, Wang S, Chellappan SP . 2002 Oncogene 21: 4539–4548

  • Harbour JW, Dean DC . 2000a Curr. Opin. Cell. Biol. 12: 685–689

  • Harbour JW, Dean DC . 2000b Nat. Cell. Biol. 2: E65–E67

  • Howe L, Brown CE, Lechner T, Workman JL . 1999 Crit. Rev. Eukaryot. Gene Expr. 9: 231–243

  • Ikonen E, Fiedler K, Parton RG, Simons K . 1995 Febs Letts. 358: 273–277

  • Johnson DG, Schwarz JK, Cress WD, Nevins JR . 1993 Nature 365: 349–352

  • Johnson DG, Schneider-Broussard R . 1998 Front Biosci. 3: d447–d448

  • Luo RX, Dean DC . 1999 J. Natl. Cancer Inst. 91: 1288–1294

  • Luo RX, Postigo AA, Dean DC . 1998 Cell 92: 463–473

  • Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW . 1998 Mol. Cell. Biol. 18: 7176–7184

  • Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A . 1998 Nature 391: 601–605

  • Martinez-Balbas M, Bauer U-M, Nielsen SJ, Brehm A, Kouzarides T . 2000 EMBO J. 19: 662–671

  • McClung JK, Jupe ER, Liu X-T, Dell'Orco RT . 1995 Exper. Gerontol. 30: 99–124

  • Meloni AR, Smith EJ, Nevins JR . 1999 Proc. Natl. Acad. Sci. USA 96: 9574–9579

  • Montano MM, Ekena K, Delage-Mourroux R, Chang W, Martini P, Katzenellenbogen BS . 1999 Proc. Natl. Acad. Sci. USA 96: 6947–6952

  • Muller H, Helin K . 2000 Biochim. Biophys. Acta 1470: M1–M12

  • Nevins JR . 1998 Cell Growth Differ. 9: 585–593

  • Nielsen SJ, Schneider R, Bauer IM, Bannister AJ, Morrison A, O'Carroll D, Firestein R, Cleary M, Jenuwein T, Herrera RE, Kouzarides T . 2001 Nature 412: 561–565

  • Nijtmans LG, Artal SM, Grivell LA, Coates PJ . 2002 Cell Mol. Life Sci. 59: 143–155

  • Nijtmans LG, de Jong L, Artal Sanz M, Coates PJ, Berden JA, Back JW, Muijsers AO, van der Spek H, Grivell LA . 2000 EMBO J. 19: 2444–2451

  • Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP . 2000 Nat. Genet. 25: 338–342

  • Ross JF, Liu X, Dynlacht BD . 1999 Mol. Cell. 3: 195–205

  • Sambrook J, Fritsch E, Maniatis T . 1989 Molecular Cloning: Laboratory Manual 2nd edn Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press pp. 16.59–16.62

    Google Scholar 

  • Steglich G, Neupert W, Langer T . 1999 Mol. Cell. Biol. 19: 3435–3442

  • Terashima M, Kim KM, Adachi T, Nielsen PJ, Reth M, Kohler G, Lamers MC . 1994 EMBO J. 13: 3782–3792

  • Thompson WE, Powell JM, Whittaker JA, Sridaran R, Thomas KH . 1999 Anat. Rec. 256: 40–48

  • Wang S, Nath N, Adlam M, Chellappan S . 1999a Oncogene 18: 3501–3510

  • Wang S, Nath N, Fusaro G, Chellappan S . 1999b Mol. Cell. Biol. 19: 7447–7460

  • Wang S, Ghosh R, Chellappan S . 1998 Mol. Cell. Biol. 18: 7487–7498

  • Weintraub SJ, Prater CA, Dean DC . 1992 Nature 358: 259–261

  • Xu L, Rosenfeld MG . 1999 Curr. Opin. Genet. Dev. 9: 140–147

  • Zhang Y, Chellappan SP . 1995 Oncogene 10: 2085–2093

  • Zhang SH, Gavin M, Dahiya A, Postigo AA, Ma S, Luo RX, Harbour JW, Dean DC . 2000 Cell 101: 79–89

Download references

Acknowledgements

We thank Scott Hiebert for helpful discussions and generous gift of reagents, and Joseph Nevins for different reporters and the GAL4-Rb construct. This work was supported by the grant CA 77301 from the NCI to SP Chellappan. G Fusaro is a recipient of a DOD student fellowship for breast cancer research (DAMD-17-01-1-0215).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Srikumar P Chellappan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, S., Fusaro, G., Padmanabhan, J. et al. Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene 21, 8388–8396 (2002). https://doi.org/10.1038/sj.onc.1205944

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205944

Keywords

This article is cited by

Search

Quick links